Is there a generic for Teniposide?

The FDA Orange Book does not currently list an approved generic (ANDA) for Teniposide. It is available as 1 brand (NDA) application.

What is the reference-listed drug for Teniposide?

VUMON (NDA 020119, HQ SPECLT PHARMA) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Teniposide are approved?

Teniposide is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Teniposide

Teniposide is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.

Reference-listed drug:VUMON · NDA 020119

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
VUMONRLD	HQ SPECLT PHARMA	NDA 020119	—	Jul 14, 1992

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Teniposide — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo